CSL buys stem cell therapy firm Calimmune – Sky News Australia
Sky News Australia |
CSL buys stem cell therapy firm Calimmune
Sky News Australia The acquisition will provide CSL Behring, CSL's blood products business, with Calimmune's haematopoietic stem cell gene therapy which is being developed for the treatment of sickle cell disease and b-thalassemia. The deal requires an an up-front … CSL acquires biotech company & stem cell gene platform Is CSL Limited buying its way to growth? In The News |
